NYSE: HQL

abrdn Life Sciences Investors (HQL)

abrdn Life Sciences Investors is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker HQL. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
HQL
Exchange
NYSE
SEC CIK
884121
Official filings
SEC EDGAR

Research HQL

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is abrdn Life Sciences Investors's stock ticker?

abrdn Life Sciences Investors trades under the ticker symbol HQL on NYSE. Its SEC Central Index Key (CIK) is 884121.

Where can I read abrdn Life Sciences Investors's SEC filings?

The HQL SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports abrdn Life Sciences Investors has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze HQL's financial statements?

The HQL Financials page shows abrdn Life Sciences Investors's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does HQL compare with its peers and the market?

The HQL Peer Comparison page lines abrdn Life Sciences Investors up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.